Nasdaq · Common stock
Aclaris Therapeutics (ACRS)
$3.79 +$0.04 (+1.07%)
- Day’s range
- $3.72–$3.85
- Volume
- 1.6M
ACRS price history
ACRS closed at $3.79 on Oct. 26, 2026. Over the past year, its daily close ranged from $2.13 on Nov. 10, 2025 to $6.54 on Aug. 25, 2026.
Data table: ACRS daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $3.79 |
| Oct. 23, 2026 | $3.75 |
| Oct. 22, 2026 | $3.83 |
| Oct. 21, 2026 | $3.81 |
| Oct. 20, 2026 | $3.77 |
| Oct. 19, 2026 | $3.48 |
| Oct. 16, 2026 | $3.28 |
| Oct. 15, 2026 | $3.49 |
| Oct. 14, 2026 | $3.38 |
| Oct. 13, 2026 | $3.47 |
| Oct. 12, 2026 | $3.60 |
| Oct. 9, 2026 | $3.83 |
| Oct. 8, 2026 | $3.79 |
| Oct. 7, 2026 | $3.40 |
| Oct. 6, 2026 | $3.70 |
| Oct. 5, 2026 | $4.27 |
| Oct. 2, 2026 | $4.39 |
| Oct. 1, 2026 | $4.41 |
| Sept. 30, 2026 | $5.26 |
| Sept. 29, 2026 | $5.28 |
| Sept. 28, 2026 | $5.43 |
| Sept. 25, 2026 | $5.15 |
| Sept. 24, 2026 | $5.38 |
| Sept. 23, 2026 | $5.26 |
| Sept. 22, 2026 | $5.72 |
| Sept. 21, 2026 | $5.57 |
| Sept. 18, 2026 | $5.50 |
| Sept. 17, 2026 | $5.40 |
| Sept. 16, 2026 | $5.32 |
| Sept. 15, 2026 | $5.53 |
| Sept. 14, 2026 | $5.64 |
| Sept. 11, 2026 | $5.32 |
| Sept. 10, 2026 | $5.51 |
| Sept. 9, 2026 | $5.56 |
| Sept. 8, 2026 | $6.06 |
| Sept. 4, 2026 | $6.17 |
| Sept. 3, 2026 | $5.95 |
| Sept. 2, 2026 | $6.18 |
| Sept. 1, 2026 | $6.02 |
| Aug. 31, 2026 | $6.05 |
| Aug. 28, 2026 | $6.01 |
| Aug. 27, 2026 | $6.16 |
| Aug. 26, 2026 | $6.19 |
| Aug. 25, 2026 | $6.54 |
| Aug. 24, 2026 | $6.31 |
| Aug. 21, 2026 | $6.41 |
| Aug. 20, 2026 | $6.33 |
| Aug. 19, 2026 | $6.44 |
| Aug. 18, 2026 | $6.31 |
| Aug. 17, 2026 | $5.92 |
| Aug. 14, 2026 | $5.78 |
| Aug. 13, 2026 | $5.86 |
| Aug. 12, 2026 | $5.84 |
| Aug. 11, 2026 | $5.92 |
| Aug. 10, 2026 | $5.90 |
| Aug. 7, 2026 | $5.91 |
| Aug. 6, 2026 | $6.09 |
| Aug. 5, 2026 | $6.36 |
| Aug. 4, 2026 | $5.98 |
| Aug. 3, 2026 | $5.53 |
| July 31, 2026 | $5.20 |
| July 30, 2026 | $5.32 |
| July 29, 2026 | $5.12 |
| July 28, 2026 | $5.33 |
| July 27, 2026 | $5.37 |
| July 24, 2026 | $5.23 |
| July 23, 2026 | $5.48 |
| July 22, 2026 | $5.62 |
| July 21, 2026 | $5.69 |
| July 20, 2026 | $5.57 |
| July 17, 2026 | $5.68 |
| July 16, 2026 | $5.36 |
| July 15, 2026 | $5.60 |
| July 14, 2026 | $5.43 |
| July 13, 2026 | $5.50 |
| July 10, 2026 | $5.58 |
| July 9, 2026 | $5.71 |
| July 8, 2026 | $5.51 |
| July 7, 2026 | $5.62 |
| July 6, 2026 | $5.49 |
| July 2, 2026 | $5.56 |
| July 1, 2026 | $5.34 |
| June 30, 2026 | $5.29 |
| June 29, 2026 | $5.02 |
| June 26, 2026 | $5.00 |
| June 25, 2026 | $4.91 |
| June 24, 2026 | $4.79 |
| June 23, 2026 | $4.92 |
| June 22, 2026 | $4.84 |
| June 18, 2026 | $4.50 |
| June 17, 2026 | $4.42 |
| June 16, 2026 | $4.34 |
| June 15, 2026 | $4.36 |
| June 12, 2026 | $4.32 |
| June 11, 2026 | $4.37 |
| June 10, 2026 | $4.10 |
| June 9, 2026 | $4.30 |
| June 8, 2026 | $4.36 |
| June 5, 2026 | $4.36 |
| June 4, 2026 | $4.71 |
| June 3, 2026 | $4.42 |
| June 2, 2026 | $4.63 |
| June 1, 2026 | $4.34 |
| May 29, 2026 | $4.55 |
| May 28, 2026 | $4.57 |
| May 27, 2026 | $4.58 |
| May 26, 2026 | $4.51 |
| May 22, 2026 | $4.52 |
| May 21, 2026 | $4.54 |
| May 20, 2026 | $4.53 |
| May 19, 2026 | $4.45 |
| May 18, 2026 | $4.40 |
| May 15, 2026 | $4.52 |
| May 14, 2026 | $4.80 |
| May 13, 2026 | $5.09 |
| May 12, 2026 | $4.88 |
| May 11, 2026 | $4.95 |
| May 8, 2026 | $4.93 |
| May 7, 2026 | $4.86 |
| May 6, 2026 | $4.78 |
| May 5, 2026 | $4.75 |
| May 4, 2026 | $4.53 |
| May 1, 2026 | $4.41 |
| April 30, 2026 | $4.34 |
| April 29, 2026 | $4.47 |
| April 28, 2026 | $4.22 |
| April 27, 2026 | $4.41 |
| April 24, 2026 | $4.30 |
| April 23, 2026 | $4.55 |
| April 22, 2026 | $4.39 |
| April 21, 2026 | $4.17 |
| April 20, 2026 | $4.25 |
| April 17, 2026 | $4.25 |
| April 16, 2026 | $3.98 |
| April 15, 2026 | $3.93 |
| April 14, 2026 | $3.92 |
| April 13, 2026 | $3.90 |
| April 10, 2026 | $4.04 |
| April 9, 2026 | $4.08 |
| April 8, 2026 | $3.95 |
| April 7, 2026 | $3.75 |
| April 6, 2026 | $3.80 |
| April 2, 2026 | $4.20 |
| April 1, 2026 | $4.14 |
| March 31, 2026 | $3.75 |
| March 30, 2026 | $3.49 |
| March 27, 2026 | $3.52 |
| March 26, 2026 | $3.52 |
| March 25, 2026 | $3.59 |
| March 24, 2026 | $3.30 |
| March 23, 2026 | $3.58 |
| March 20, 2026 | $3.69 |
| March 19, 2026 | $3.74 |
| March 18, 2026 | $3.66 |
| March 17, 2026 | $3.88 |
| March 16, 2026 | $3.74 |
| March 13, 2026 | $3.54 |
| March 12, 2026 | $3.51 |
| March 11, 2026 | $3.60 |
| March 10, 2026 | $3.67 |
| March 9, 2026 | $3.39 |
| March 6, 2026 | $3.06 |
| March 5, 2026 | $3.12 |
| March 4, 2026 | $3.10 |
| March 3, 2026 | $3.04 |
| March 2, 2026 | $3.05 |
| Feb. 27, 2026 | $2.87 |
| Feb. 26, 2026 | $3.13 |
| Feb. 25, 2026 | $3.31 |
| Feb. 24, 2026 | $3.36 |
| Feb. 23, 2026 | $3.25 |
| Feb. 20, 2026 | $3.24 |
| Feb. 19, 2026 | $3.23 |
| Feb. 18, 2026 | $3.17 |
| Feb. 17, 2026 | $3.26 |
| Feb. 13, 2026 | $3.19 |
| Feb. 12, 2026 | $3.36 |
| Feb. 11, 2026 | $3.39 |
| Feb. 10, 2026 | $3.65 |
| Feb. 9, 2026 | $3.69 |
| Feb. 6, 2026 | $3.57 |
| Feb. 5, 2026 | $3.39 |
| Feb. 4, 2026 | $3.54 |
| Feb. 3, 2026 | $3.47 |
| Feb. 2, 2026 | $3.61 |
| Jan. 30, 2026 | $3.51 |
| Jan. 29, 2026 | $3.43 |
| Jan. 28, 2026 | $3.51 |
| Jan. 27, 2026 | $3.87 |
| Jan. 26, 2026 | $3.82 |
| Jan. 23, 2026 | $4.50 |
| Jan. 22, 2026 | $4.53 |
| Jan. 21, 2026 | $4.42 |
| Jan. 20, 2026 | $4.43 |
| Jan. 16, 2026 | $2.62 |
| Jan. 15, 2026 | $2.67 |
| Jan. 14, 2026 | $2.74 |
| Jan. 13, 2026 | $2.71 |
| Jan. 12, 2026 | $2.66 |
| Jan. 9, 2026 | $2.64 |
| Jan. 8, 2026 | $2.68 |
| Jan. 7, 2026 | $2.68 |
| Jan. 6, 2026 | $2.65 |
| Jan. 5, 2026 | $2.65 |
| Jan. 2, 2026 | $2.88 |
| Dec. 31, 2025 | $3.01 |
| Dec. 30, 2025 | $2.90 |
| Dec. 29, 2025 | $3.01 |
| Dec. 26, 2025 | $3.03 |
| Dec. 24, 2025 | $3.04 |
| Dec. 23, 2025 | $2.90 |
| Dec. 22, 2025 | $3.07 |
| Dec. 19, 2025 | $3.14 |
| Dec. 18, 2025 | $3.08 |
| Dec. 17, 2025 | $3.03 |
| Dec. 16, 2025 | $3.21 |
| Dec. 15, 2025 | $3.17 |
| Dec. 12, 2025 | $3.25 |
| Dec. 11, 2025 | $3.36 |
| Dec. 10, 2025 | $3.27 |
| Dec. 9, 2025 | $3.21 |
| Dec. 8, 2025 | $3.28 |
| Dec. 5, 2025 | $2.92 |
| Dec. 4, 2025 | $3.01 |
| Dec. 3, 2025 | $2.78 |
| Dec. 2, 2025 | $2.70 |
| Dec. 1, 2025 | $2.61 |
| Nov. 28, 2025 | $2.83 |
| Nov. 26, 2025 | $2.88 |
| Nov. 25, 2025 | $2.73 |
| Nov. 24, 2025 | $2.75 |
| Nov. 21, 2025 | $2.51 |
| Nov. 20, 2025 | $2.41 |
| Nov. 19, 2025 | $2.46 |
| Nov. 18, 2025 | $2.49 |
| Nov. 17, 2025 | $2.45 |
| Nov. 14, 2025 | $2.52 |
| Nov. 13, 2025 | $2.32 |
| Nov. 12, 2025 | $2.41 |
| Nov. 11, 2025 | $2.30 |
| Nov. 10, 2025 | $2.13 |
| Nov. 7, 2025 | $2.32 |
| Nov. 6, 2025 | $2.27 |
| Nov. 5, 2025 | $2.26 |
| Nov. 4, 2025 | $2.36 |
| Nov. 3, 2025 | $2.56 |
| Oct. 31, 2025 | $2.52 |
| Oct. 30, 2025 | $2.49 |
| Oct. 29, 2025 | $2.34 |
| Oct. 28, 2025 | $2.39 |
| Oct. 27, 2025 | $2.34 |
Key figures
- 52-week range
- $2.13–$6.54Low Nov. 10, 2025; high Aug. 25, 2026
- Average daily volume
- 2.8MPast 3 months
- Market value
- $529.9M
- Dividend yield
- —
- From 52-week high
- −42.00%
Price change
- 1 month
- −26.41%
- 3 months
- −27.53%
- Year to date
- +25.91%
- 1 year
- +76.28%
$1,000 a year ago
$1,000 put into ACRS at the close on Oct. 24, 2025 would be worth $1,763.
Price only, dividends not included.
What Wall Street says about ACRS
In the past 90 days, Wall Street firms published 1 rating or price-target action on ACRS: 1 new rating.
| Action | Rating | |||
|---|---|---|---|---|
| Canaccord Genuity | Initiates coverage | Buy | $10 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.
- Headquarters
- Wayne, Pa.
- Employees
- 73
- Listed
- Oct. 7, 2015
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about ACRS is on the site yet.